Prognostic Subgroups for Citalopram Response in the STAR*D Trial

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.13m08727
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Physicians Postgraduate Press, Inc

Related search

SLC6A4 Variation and Citalopram Response

American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics
PsychiatryMolecular NeuroscienceMental HealthGeneticsCellular
2009English

The STAR*D Trial: The 300 Lb Gorilla Is in the Room, but Does It Block All the Light?

Evidence-Based Mental Health
PsychiatryMental Health
2008English

Gene Expression Biomarkers of Response to Citalopram Treatment in Major Depressive Disorder

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2011English

R&D Mass Production of LMRPC Module for the STAR-MTD System

2012English

STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby!

Canadian Journal of Psychiatry
PsychiatryMental Health
2015English

Serotonin Transporter Triallelic Genotype and Response to Citalopram and Risperidone in Dementia With Behavioral Symptoms

International Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2010English

Validation of the AJCC Prognostic Stage for HER2-positive Breast Cancer in the ShortHER Trial

BMC Medicine
Medicine
2019English

Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder

American Journal of Psychiatry
PsychiatryMental Health
2010English

Prognostic Impact of Diffuse Large B-Cell Lymphoma Subgroups in Patients Undergoing Autologous SCT

Bone Marrow Transplantation
TransplantationHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy